The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 16087912.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Using protein expression profiling, the authors identified an upregulation of the chemokine B lymphocyte chemoattractant (BLC) in the CSF of patients with neuroborreliosis but not in patients with noninflammatory and various other inflammatory neurologic diseases. This upregulation was confirmed by ELISA, showing increased BLC levels in every neuroborreliosis patient while being undetectable in patients with noninflammatory neurologic diseases. These results point to BLC as a putative additional diagnostic marker for neuroborreliosis.
Medical subject headings
- Cerebrospinal Fluid
- Chemokines, CXC
- Lyme Neuroborreliosis